Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters.
Furuhashi M, Hiramitsu S, Mita T, Omori A, Fuseya T, Ishimura S, Watanabe Y, Hoshina K, Matsumoto M, Tanaka M, Moniwa N, Yoshida H, Ishii J, Miura T.
Furuhashi M, et al.
Lipids Health Dis. 2016 Jan 12;15:5. doi: 10.1186/s12944-016-0177-8.
Lipids Health Dis. 2016.
PMID: 26754658
Free PMC article.
Clinical Trial.
Change in FABP4 level by omega-3 fatty acids was negatively correlated with change in levels of EPA + DHA (r = -0.643, P = 0.013), EPA (r = -0.540, P = 0.046) and DHA (r = -0.650, P = 0.011) but not change in the level of triglycerides or other fatt …
Change in FABP4 level by omega-3 fatty acids was negatively correlated with change in levels of EPA + DHA (r = - …